Logo image of JELD

JELD-WEN HOLDING INC (JELD) Stock Fundamental Analysis

NYSE:JELD - US47580P1030 - Common Stock

6.12 USD
+0.12 (+2%)
Last: 8/28/2025, 12:02:44 PM
Fundamental Rating

2

Taking everything into account, JELD scores 2 out of 10 in our fundamental rating. JELD was compared to 41 industry peers in the Building Products industry. JELD has a bad profitability rating. Also its financial health evaluation is rather negative. JELD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year JELD was profitable.
In the past year JELD had a positive cash flow from operations.
JELD had positive earnings in 4 of the past 5 years.
In the past 5 years JELD always reported a positive cash flow from operatings.
JELD Yearly Net Income VS EBIT VS OCF VS FCFJELD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

JELD has a Return On Assets of -13.94%. This is amonst the worse of the industry: JELD underperforms 85.37% of its industry peers.
JELD has a Return On Equity of -74.29%. This is amonst the worse of the industry: JELD underperforms 90.24% of its industry peers.
Industry RankSector Rank
ROA -13.94%
ROE -74.29%
ROIC N/A
ROA(3y)-1.27%
ROA(5y)0.6%
ROE(3y)-5.61%
ROE(5y)2.47%
ROIC(3y)N/A
ROIC(5y)N/A
JELD Yearly ROA, ROE, ROICJELD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80 -100

1.3 Margins

In the last couple of years the Operating Margin of JELD has declined.
With a Gross Margin value of 16.96%, JELD is not doing good in the industry: 87.80% of the companies in the same industry are doing better.
JELD's Gross Margin has declined in the last couple of years.
JELD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.96%
OM growth 3Y-44.57%
OM growth 5Y-27.89%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.71%
GM growth 5Y-2.15%
JELD Yearly Profit, Operating, Gross MarginsJELD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

2

2. Health

2.1 Basic Checks

JELD does not have a ROIC to compare to the WACC, probably because it is not profitable.
JELD has less shares outstanding than it did 1 year ago.
JELD has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, JELD has a worse debt to assets ratio.
JELD Yearly Shares OutstandingJELD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
JELD Yearly Total Debt VS Total AssetsJELD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

JELD has an Altman-Z score of 1.58. This is a bad value and indicates that JELD is not financially healthy and even has some risk of bankruptcy.
JELD's Altman-Z score of 1.58 is on the low side compared to the rest of the industry. JELD is outperformed by 87.80% of its industry peers.
A Debt/Equity ratio of 2.42 is on the high side and indicates that JELD has dependencies on debt financing.
JELD's Debt to Equity ratio of 2.42 is on the low side compared to the rest of the industry. JELD is outperformed by 90.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.42
Debt/FCF N/A
Altman-Z 1.58
ROIC/WACCN/A
WACC8.07%
JELD Yearly LT Debt VS Equity VS FCFJELD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

JELD has a Current Ratio of 1.77. This is a normal value and indicates that JELD is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.77, JELD is not doing good in the industry: 60.98% of the companies in the same industry are doing better.
JELD has a Quick Ratio of 1.04. This is a normal value and indicates that JELD is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of JELD (1.04) is worse than 65.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.04
JELD Yearly Current Assets VS Current LiabilitesJELD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1

3. Growth

3.1 Past

The earnings per share for JELD have decreased strongly by -99.31% in the last year.
Measured over the past years, JELD shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.18% on average per year.
JELD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.16%.
Measured over the past years, JELD shows a decrease in Revenue. The Revenue has been decreasing by -2.52% on average per year.
EPS 1Y (TTM)-99.31%
EPS 3Y-24.51%
EPS 5Y-8.18%
EPS Q2Q%-111.76%
Revenue 1Y (TTM)-15.16%
Revenue growth 3Y-7.51%
Revenue growth 5Y-2.52%
Sales Q2Q%-16.46%

3.2 Future

The Earnings Per Share is expected to grow by 1.24% on average over the next years.
The Revenue is expected to decrease by -2.59% on average over the next years.
EPS Next Y-106.24%
EPS Next 2Y-38.83%
EPS Next 3Y1.24%
EPS Next 5YN/A
Revenue Next Year-12.88%
Revenue Next 2Y-5.61%
Revenue Next 3Y-2.59%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
JELD Yearly Revenue VS EstimatesJELD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
JELD Yearly EPS VS EstimatesJELD Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 612.00, JELD can be considered very expensive at the moment.
80.49% of the companies in the same industry are cheaper than JELD, based on the Price/Earnings ratio.
JELD's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.14.
The Price/Forward Earnings ratio is 21.24, which indicates a rather expensive current valuation of JELD.
The rest of the industry has a similar Price/Forward Earnings ratio as JELD.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.80, JELD is valued at the same level.
Industry RankSector Rank
PE 612
Fwd PE 21.24
JELD Price Earnings VS Forward Price EarningsJELD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 200 400 600

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of JELD is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.86
JELD Per share dataJELD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-38.83%
EPS Next 3Y1.24%

0

5. Dividend

5.1 Amount

JELD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

JELD-WEN HOLDING INC

NYSE:JELD (8/28/2025, 12:02:44 PM)

6.12

+0.12 (+2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners94.11%
Inst Owner Change-6.94%
Ins Owners1.97%
Ins Owner Change7.15%
Market Cap522.65M
Analysts49.33
Price Target4.87 (-20.42%)
Short Float %3.33%
Short Ratio1.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)31.45%
Min EPS beat(2)11.91%
Max EPS beat(2)50.98%
EPS beat(4)2
Avg EPS beat(4)-5.69%
Min EPS beat(4)-63.4%
Max EPS beat(4)50.98%
EPS beat(8)6
Avg EPS beat(8)12.41%
EPS beat(12)10
Avg EPS beat(12)60.7%
EPS beat(16)11
Avg EPS beat(16)41.57%
Revenue beat(2)0
Avg Revenue beat(2)-0.55%
Min Revenue beat(2)-0.93%
Max Revenue beat(2)-0.17%
Revenue beat(4)1
Avg Revenue beat(4)-1.69%
Min Revenue beat(4)-7.55%
Max Revenue beat(4)1.9%
Revenue beat(8)2
Avg Revenue beat(8)-1.6%
Revenue beat(12)5
Avg Revenue beat(12)-0.46%
Revenue beat(16)6
Avg Revenue beat(16)-2.11%
PT rev (1m)10.75%
PT rev (3m)-27.78%
EPS NQ rev (1m)16.16%
EPS NQ rev (3m)-63.59%
EPS NY rev (1m)68.78%
EPS NY rev (3m)-90.85%
Revenue NQ rev (1m)3.47%
Revenue NQ rev (3m)-2.44%
Revenue NY rev (1m)2.35%
Revenue NY rev (3m)1.56%
Valuation
Industry RankSector Rank
PE 612
Fwd PE 21.24
P/S 0.15
P/FCF N/A
P/OCF 30.92
P/B 1.1
P/tB 2.9
EV/EBITDA 15.86
EPS(TTM)0.01
EY0.16%
EPS(NY)0.29
Fwd EY4.71%
FCF(TTM)-1.86
FCFYN/A
OCF(TTM)0.2
OCFY3.23%
SpS40.17
BVpS5.59
TBVpS2.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.94%
ROE -74.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.96%
FCFM N/A
ROA(3y)-1.27%
ROA(5y)0.6%
ROE(3y)-5.61%
ROE(5y)2.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.38%
ROCE(5y)6.41%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-44.57%
OM growth 5Y-27.89%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.71%
GM growth 5Y-2.15%
F-Score2
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 2.42
Debt/FCF N/A
Debt/EBITDA 11.77
Cap/Depr 158.55%
Cap/Sales 5.12%
Interest Coverage N/A
Cash Conversion 17.22%
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 1.04
Altman-Z 1.58
F-Score2
WACC8.07%
ROIC/WACCN/A
Cap/Depr(3y)95.72%
Cap/Depr(5y)86.36%
Cap/Sales(3y)2.99%
Cap/Sales(5y)2.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-99.31%
EPS 3Y-24.51%
EPS 5Y-8.18%
EPS Q2Q%-111.76%
EPS Next Y-106.24%
EPS Next 2Y-38.83%
EPS Next 3Y1.24%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.16%
Revenue growth 3Y-7.51%
Revenue growth 5Y-2.52%
Sales Q2Q%-16.46%
Revenue Next Year-12.88%
Revenue Next 2Y-5.61%
Revenue Next 3Y-2.59%
Revenue Next 5YN/A
EBIT growth 1Y-114.66%
EBIT growth 3Y-48.73%
EBIT growth 5Y-29.71%
EBIT Next Year990.51%
EBIT Next 3Y157.53%
EBIT Next 5YN/A
FCF growth 1Y-164.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-95.16%
OCF growth 3Y-15.45%
OCF growth 5Y-18.9%